Search
for
Sort by
Research 511–540 of 982
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Male hormonal contraception: looking back and moving forward
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- The challenges with managing polycystic ovary syndrome: A qualitative study of women’s and clinicians’ experiences
- Is polycystic ovary syndrome a sexual conflict? A review
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Prevalence of cervical insufficiency in polycystic ovarian syndrome
- PCOS in lesbian and heterosexual women treated with artificial donor insemination
- Alopecia Possibly Secondary to Topical Ophthalmic β-Blockers
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Genetic basis of polycystic ovary syndrome
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- ALLETHRIN INDUCED TOXICOPATHOLOGICAL ALTERATIONS IN ADULT MALE ALBINO RATS
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- A Case of Kerion Celsi Caused by Microsporum gypseum (Arthroderma gypseum ) in a Child
- Polycystic Ovarian Syndrome in Adolescents
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
- Therapeutic options in the polycystic ovary syndrome
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study